Skip to main content

Wolfgang Rottbauer, MD

Case Report
06/08/2010
   ABSTRACT: An 86-year-old female patient was admitted to our hospital with a stenosed biological mitral valve prothesis (orifice area 0.75 cm2). Additional cardiac surgery was refused by the patient and her physician. Therefore, balloon...
   ABSTRACT: An 86-year-old female patient was admitted to our hospital with a stenosed biological mitral valve prothesis (orifice area 0.75 cm2). Additional cardiac surgery was refused by the patient and her physician. Therefore, balloon...
   ABSTRACT: An 86-year-old...
06/08/2010
Journal of Invasive Cardiology
Original Contribution
03/30/2017
This study compares early device success, procedural success, and 30-day safety endpoint according to the new Mitral Valve Academic Research Consortium criteria (MVARC) in severe primary and secondary mitral regurgitation (MR) patients.
This study compares early device success, procedural success, and 30-day safety endpoint according to the new Mitral Valve Academic Research Consortium criteria (MVARC) in severe primary and secondary mitral regurgitation (MR) patients.
This study compares early device...
03/30/2017
Journal of Invasive Cardiology
Original Contribution
03/01/2022
Transradial access for coronary angiography was observed to be superior to femoral access. Nevertheless, femoral artery access is still frequently used, especially in challenging subgroups with high procedural complexity, like patients with...
Transradial access for coronary angiography was observed to be superior to femoral access. Nevertheless, femoral artery access is still frequently used, especially in challenging subgroups with high procedural complexity, like patients with...
Transradial access for coronary...
03/01/2022
Journal of Invasive Cardiology